Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
Incyte Corporation
Incyte Corporation
Sierra Oncology LLC - a GSK company
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
OHSU Knight Cancer Institute